Tokyo, Japan

Haruko Yamabe




Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2005-2012

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Haruko Yamabe: A Pioneer in Pharmaceutical Innovations

Introduction

Haruko Yamabe is a distinguished inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative research and development of novel compounds. With a total of 3 patents to her name, her work continues to impact the medical community.

Latest Patents

Yamabe's latest patents include groundbreaking compounds such as dihydropseudoerythromycin derivatives. This compound is represented by the formula [I], wherein each symbol is defined in the specification or as a pharmacologically acceptable salt thereof. Additionally, she has developed cyclic amide derivatives, which are novel compounds acting as ligands to sigma receptors. These compounds are characterized by a specific formula that includes various groups and atoms, showcasing her expertise in medicinal chemistry.

Career Highlights

Throughout her career, Haruko Yamabe has worked with prominent organizations, including Mitsubishi Pharma Corporation and The Kitasato Institute. Her experience in these institutions has allowed her to refine her skills and contribute to significant advancements in pharmaceutical research.

Collaborations

Yamabe has collaborated with notable colleagues such as Masahiro Okuyama and Akira Nakao. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Haruko Yamabe's contributions to the field of pharmaceuticals through her patents and collaborations highlight her as a leading figure in innovation. Her work continues to inspire future generations of inventors and researchers in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…